HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasushi Yatabe Selected Research

Yasushi Yatabe Research Topics

Disease

158Neoplasms (Cancer)
11/2022 - 04/2002
94Lung Neoplasms (Lung Cancer)
11/2021 - 01/2002
58Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2005
38Adenocarcinoma
11/2022 - 06/2002
27Adenocarcinoma of Lung
01/2022 - 06/2002
26Neoplasm Metastasis (Metastasis)
11/2021 - 01/2002
19Stomach Neoplasms (Stomach Cancer)
01/2021 - 07/2008
16Carcinoma (Carcinomatosis)
01/2022 - 09/2004
16Breast Neoplasms (Breast Cancer)
12/2019 - 05/2004
15Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 07/2008
9Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2021 - 04/2002
9Carcinogenesis
07/2013 - 01/2002
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2013 - 04/2004
7Lymphoma (Lymphomas)
08/2019 - 07/2004
6Malignant Mesothelioma
01/2022 - 03/2007
6Squamous Cell Carcinoma of Head and Neck
01/2021 - 11/2012
6Disease Progression
11/2017 - 01/2007
5Circulating Neoplastic Cells
09/2019 - 01/2014
4Lymphatic Metastasis
12/2021 - 11/2012
4Inflammation (Inflammations)
12/2018 - 05/2010
4Mesothelioma
01/2017 - 11/2008
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
10/2015 - 01/2007
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2013 - 01/2010
3Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2022 - 01/2019
3Sarcoma (Soft Tissue Sarcoma)
01/2021 - 08/2010
3Ascites
01/2021 - 05/2012
3Residual Neoplasm
06/2018 - 05/2015
3Colonic Neoplasms (Colon Cancer)
01/2018 - 02/2010
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2017 - 11/2007
3Ductal Carcinoma
03/2016 - 01/2007
3Small Cell Carcinoma
12/2009 - 08/2007

Drug/Important Bio-Agent (IBA)

60ErbB Receptors (EGF Receptor)IBA
12/2021 - 05/2004
43Tyrosine Kinase InhibitorsIBA
12/2021 - 10/2003
26Gefitinib (Iressa)FDA Link
11/2017 - 10/2003
20Biomarkers (Surrogate Marker)IBA
11/2021 - 06/2006
20Proteins (Proteins, Gene)FDA Link
11/2021 - 05/2004
17Anaplastic Lymphoma KinaseIBA
09/2019 - 10/2010
16Phosphotransferases (Kinase)IBA
02/2022 - 07/2004
13Pharmaceutical PreparationsIBA
02/2022 - 05/2007
12Trastuzumab (Herceptin)FDA Link
01/2021 - 03/2005
11DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2002
11Biological ProductsIBA
04/2021 - 12/2004
10Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2017 - 06/2006
8B7-H1 AntigenIBA
01/2022 - 07/2015
8RNA (Ribonucleic Acid)IBA
01/2022 - 12/2004
8NivolumabIBA
12/2021 - 10/2016
8Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2011 - 04/2004
7Transcription Factors (Transcription Factor)IBA
01/2022 - 06/2002
7CrizotinibIBA
10/2021 - 08/2013
7AntibodiesIBA
01/2020 - 05/2010
7Estrogen ReceptorsIBA
12/2013 - 01/2007
6MucinsIBA
11/2022 - 05/2004
6ParaffinIBA
12/2021 - 04/2006
6alectinibIBA
01/2021 - 01/2016
6Cell-Free Nucleic AcidsIBA
06/2020 - 05/2016
6Cisplatin (Platino)FDA LinkGeneric
08/2017 - 06/2008
6Bevacizumab (Avastin)FDA Link
01/2017 - 02/2011
6MicroRNAs (MicroRNA)IBA
12/2015 - 06/2004
6EnzymesIBA
08/2010 - 01/2002
5Thyroid Nuclear Factor 1IBA
01/2022 - 04/2008
5Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2021 - 07/2004
5human ERBB2 proteinIBA
08/2018 - 05/2011
5Messenger RNA (mRNA)IBA
08/2018 - 06/2008
5Docetaxel (Taxotere)FDA Link
11/2017 - 02/2010
4Monoclonal AntibodiesIBA
01/2022 - 07/2008
4Pemetrexed (MTA)FDA Link
10/2019 - 02/2011
4PlatinumIBA
08/2017 - 12/2015
4Aldehyde DehydrogenaseIBA
06/2016 - 04/2010
4Cetuximab (Erbitux)FDA Link
03/2016 - 07/2008
3Keratins (Keratin)IBA
01/2022 - 09/2004
3Immune Checkpoint InhibitorsIBA
01/2022 - 04/2016
3Formaldehyde (Formol)FDA Link
12/2021 - 01/2015
3osimertinibIBA
12/2021 - 09/2018
3AmylasesFDA Link
01/2021 - 01/2007
3ORALIT (ORS)IBA
01/2020 - 07/2013
3Cadherins (E-Cadherin)IBA
01/2018 - 03/2008
3lysyllysine (Lys-Lys)IBA
06/2016 - 04/2010
3glutamyl-glutamic acid (Glu-Glu)IBA
06/2016 - 08/2010
3LigandsIBA
04/2016 - 02/2008
3Progesterone Receptors (Progesterone Receptor)IBA
04/2016 - 01/2007
3Phenobarbital (Luminal)FDA Link
03/2016 - 12/2012
3Epidermal Growth Factor (EGF)IBA
01/2014 - 12/2012
3Folic Acid (Vitamin M)FDA LinkGeneric
03/2012 - 08/2007
3Irinotecan (Camptosar)FDA LinkGeneric
08/2011 - 07/2010
3Oncogene Proteins (Oncogene Protein)IBA
08/2011 - 11/2008
2pembrolizumabIBA
12/2021 - 11/2018

Therapy/Procedure

52Therapeutics
02/2022 - 08/2003
30Drug Therapy (Chemotherapy)
11/2021 - 04/2006
8Radiotherapy
11/2021 - 04/2006
6Immunotherapy
11/2021 - 04/2016
4Molecular Targeted Therapy
01/2022 - 01/2017
4Neck Dissection (Radical Neck Dissection)
01/2021 - 02/2006
4Lymph Node Excision (Lymph Node Dissection)
12/2019 - 04/2013
4Mastectomy (Mammectomy)
01/2019 - 01/2007
4Combination Drug Therapy (Combination Chemotherapy)
03/2015 - 07/2010
3Precision Medicine
01/2022 - 05/2014
3Adjuvant Chemotherapy
12/2021 - 04/2012
3Neoadjuvant Therapy
01/2020 - 02/2014
3Radiofrequency Ablation
12/2018 - 08/2016
2Lasers (Laser)
01/2022 - 06/2007